InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
3
T+90 hit rate
100%
T+90 mean return
+23.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Aselage Steve, Director. Officer active across 4 companies, notably Travere Therapeutics, Inc.. In total, 20 disclosures have been logged. Breakdown: 3 buys · 3 sells. Total volume traded: €1.4m. History available since 11 May 2021. The latest transaction was disclosed on 12 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Aselage Steve
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
6,820 shares0Common StockSEC:0001127602-24-018708:0
2,500 shares@ US$6.4025.6% of flowCommon StockSEC:0001127602-24-016776:0
Canonical exit: 22 Aug 2024 (T+90)
483,741 sharesCommon Stock, $0.0001 par value per shareSEC:0000899243-23-020445:0
16,745 shares0Common StockSEC:0001127602-23-018786:0
409,836 shares@ US$1.2298.4% of flowCommon StockSEC:0001209191-22-059172:0
Canonical exit: 27 Feb 2023 (T+90)
12,866 shares0Common StockSEC:0001127602-22-017138:0
569 shares@ US$9.310.0003% mcap11.4% of flowCommon StockSEC:0001127602-22-016409:0
2,575 shares@ US$21.92490.0014% mcap1.4% of flowCommon StockSEC:0001209191-22-028702:0
301 shares@ US$16.610.0003% mcap10.4% of flowCommon StockSEC:0001127602-22-007717:0
2,016 shares@ US$2.150.8% of flowCommon StockSEC:0001209191-21-069227:0
Canonical exit: 9 Mar 2022 (T+90)
414 shares@ US$12.0610.8% of flowCommon StockSEC:0001127602-21-030063:0
31,800 shares@ US$29.3943.4% of flowCommon StockSEC:0001209191-21-065439:0
10,000 shares@ US$16.237.4% of flowCommon StockSEC:0001209191-21-063591:0
25,000 shares0Common StockSEC:0001209191-21-062670:0
60,000 shares@ US$16.2344.5% of flowCommon StockSEC:0001209191-21-060035:0
314 shares@ US$15.9210.3% of flowCommon StockSEC:0001127602-21-024772:0
634 shares@ US$15.7720.0% of flowCommon StockSEC:0001127602-21-018470:0
3,000 shares0Common StockSEC:0001209191-21-033851:0
2,146 shares@ US$19.5821.8% of flowCommon StockSEC:0001209191-21-032312:0
3,000 sharesCommon StockSEC:0001209191-16-094260:0
20 of 20 declarations
About Aselage Steve
ASELAGE STEVE is Administrateur. He has 20 filings in total, and across the recent sample of 20 filings, the observed buy and sell amounts are EUR 501918 and EUR 910551, respectively, from 2016-01-29 to 2024-06-14. His listed companies are Biocryst Pharmaceuticals INC, Travere Therapeutics, Inc., Acer Therapeutics Inc. and Retrophin, Inc., and the modal transaction nature indicated is Attribution.
